Obstructive Sleep Apnea Management in Children Despite Adenotonsillectomy: Guidelines From the American Thoracic Society

Michael J. Arnold, MD, MHPE

American Family Physician. 2025;111(5):476-477.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Obstructive sleep apnea (OSA), with repeated episodes of upper airway obstruction during sleep, affects up to 5% of children. Although adenotonsillectomy is the first-line management for OSA in children, up to 40% of children will have five or more apnea or hypopnea episodes per hour (ie, apnea–hypopnea index of 5 or more) while sleeping despite surgery. The risk of persistent OSA is greater in children with an apnea–hypopnea index of 10 or more at baseline (indicating severe OSA), obesity, craniofacial or genetic disorders, or chronic cardiopulmonary and neuromuscular disorders. The American Thoracic Society (ATS) published guidelines on the management of persistent OSA in children after adenotonsillectomy. All recommendations are suggestions that apply to some patients, but they are not strong recommendations because of very low-quality evidence.

• In children 6 years of age to the onset of puberty with persistent OSA despite adenotonsillectomy and posterior crossbite, rapid maxillary expansion can resolve OSA.

• Drug-induced sleep endoscopy can diagnose lingual tonsillar hypertrophy and sleep-dependent laryngomalacia, which can both be addressed through surgical intervention.

• CPAP therapy should be considered in children who are not candidates for other treatments; it can reduce the number of apnea and hypopnea episodes, snoring, and excessive daytime sleepiness, although many patients do not tolerate the intervention.

• Weight loss interventions are suggested for obese children with persistent OSA based on evidence of benefit from observational studies in nonpersistent OSA.

From the AFP Editors

ORTHODONTIC TREATMENT

Up to 22% of children with persistent OSA will have maxillary constriction because of posterior crossbite, in which the upper and lower back teeth do not mesh properly due to the narrow width of one arch compared with the other. For these patients, the guidelines suggest rapid maxillary expansion via orthodonture using a palatal expander in patients from the eruption of the first molars at 6 or 7 years of age to the onset of puberty.

Observational studies demonstrate that rapid maxillary expansion reduces average apnea–hypopnea index to less than 1 per hour in patients with persistent OSA after surgery and maxillary constriction. Most children also experience an improvement in snoring. Adverse effects include the inability to make clicking sounds with the tongue, inability to protrude the tongue toward the nose, and, less commonly, difficulty swallowing liquids.

SURGICAL OPTIONS

Lingual Tonsillectomy

Hypertrophy of lingual tonsils resulting in tongue elevation that produces airway obstruction of 50% or greater is a common cause of persistent OSA. This cause of airway obstruction can be measured by drug-induced sleep endoscopy or imaging studies.

The guidelines suggest lingual tonsillectomy in children with lingual tonsillar hypertrophy based on very low-quality evidence of improving apnea–hypopnea index. Up to 19% of patients who undergo this procedure will develop airway edema, and up to 8% will experience adhesions between the epiglottis and tongue base.

Supraglottoplasty

Sleep-dependent laryngomalacia, commonly caused by the inspiratory collapse of redundant mucosa in the supra-arytenoid larynx, is an increasingly recognized cause of persistent OSA. Sleep-dependent laryngomalacia is best diagnosed via drug-induced sleep endoscopy.

The guidelines suggest supraglottoplasty based on very low-quality evidence of improving apnea–hypopnea index and snoring. Adverse effects include coughing, throat clearing, and dysphagia that can be transient or prolonged.

MICHAEL J. ARNOLD, MD, MHPE, Naval Undersea Medical Institute, Groton, Connecticut

Address correspondence to Michael J. Arnold, MD, MHPE, at mkcarnold@gmail.com.

Author disclosure: No relevant financial relationships.

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Michael J. Arnold, MD, MHPE, AFP Assistant Medical Editor.

A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.